Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.

Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9

Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)

Cruz CV. et al, (2024), Wellcome Open Research, 9, 342 - 342

Death from diphtheria.

White NJ., (2024), Lancet (London, England), 403, 2590 - 2591

Rectal artesunate: lives not saved.

White NJ. et al, (2024), Trans R Soc Trop Med Hyg

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants

Wattanakul T. et al, (2024), Nature Communications, 15

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria

Saito M. et al, (2024), Antimicrobial Agents and Chemotherapy, 68

The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis

Singh S. et al, (2024), Journal of Antimicrobial Chemotherapy, 79, 935 - 945

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Thu AM. et al, (2024), Malaria journal, 23

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match.

Cokljat M. et al, (2024), BMJ Glob Health, 9

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

Wongnak P. et al, (2024), The Lancet Infectious Diseases

Where will rectal artesunate suppositories save lives?

Watson JA. et al, (2024), The Lancet, 403, 1137 - 1138

Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.

Watson JA. et al, (2023), PLoS Med, 20

A systematic review of neglected tropical diseases (NTDs) in Myanmar.

Swe MMM. et al, (2023), PLoS neglected tropical diseases, 17

Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis.

Zaw AS. et al, (2023), PLoS medicine, 20

Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study

Fanello C. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 109, 965 - 974

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

Mehdipour P. et al, (2023), Malaria journal, 22

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522

Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria

Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

Thriemer K. et al, (2023), BMC Medical Research Methodology, 23

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?